Position in OGN
as of Mar 31, 2026
· filed Apr 8, 2026
Position Value
$83,512
-$69,404 QoQ
Shares Held
13,942
-2.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bill Few Associates, Inc. holds $19,934,189 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
38,621 | $9,718,588 | |
| 2 | JNJ |
Johnson & Johnson
|
9,146 | $2,322,809 | |
| 3 | LLY |
ELI LILLY & Co
|
1,850 | $2,218,945 | |
| 4 | PFE |
Pfizer Inc
|
91,121 | $2,194,193 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,418 | $1,595,713 | |
| 6 | AMGN |
Amgen Inc
|
2,180 | $789,421 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,876 | $684,295 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,247 | $410,225 |
All Filings in OGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,512 | 13,942 | Shares | Sole | 2026-04-08 | |
| 2025-09-30 | $152,916 | 14,318 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $145,529 | 15,034 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $213,567 | 14,343 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $206,880 | 13,866 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $240,712 | 12,583 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $252,912 | 12,218 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $218,023 | 11,597 | Shares | Sole | 2024-04-18 | |
| No filing history on record for this holder in this stock. | ||||||